Log in

CNSX:LHSLiberty Health Sciences Stock Price, Forecast & News

$0.53
-0.02 (-3.64 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.51
Now: $0.53
$0.53
50-Day Range N/A
52-Week Range
$0.63
Now: $0.53
$2.30
Volume636,873 shs
Average Volume346,771 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis primarily in the State of Florida. It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis. The company is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-647-7254185

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees75
Next Earnings DateN/A
OptionableNot Optionable

Receive LHS News and Ratings via Email

Sign-up to receive the latest news and ratings for LHS and its competitors with MarketBeat's FREE daily newsletter.

Liberty Health Sciences (CNSX:LHS) Frequently Asked Questions

Has Liberty Health Sciences been receiving favorable news coverage?

Press coverage about LHS stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Liberty Health Sciences earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the next several days. View the latest news aboutLiberty Health Sciences.

Who are some of Liberty Health Sciences' key competitors?

What other stocks do shareholders of Liberty Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Health Sciences investors own include Canopy Growth (WEED), Aphria (APHA), Aurora Cannabis (ACB), OrganiGram (OGI), Supreme Cannabis (FIRE), Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), Cronos Group (CRON), Cross Timbers Royalty Trust (CRT) and Curaleaf (CURLF).

Who are Liberty Health Sciences' key executives?

Liberty Health Sciences' management team includes the following people:
  • Mr. Victor E. Mancebo, Interim CEO & Pres
  • Mr. Brady Cobb, Pres
  • Mr. Jeffrey Chan, Interim Chief Financial Officer
  • Ms. Stephanie Kubacki, VP of Marketing

What is Liberty Health Sciences' stock symbol?

Liberty Health Sciences trades on the CNSX under the ticker symbol "LHS."

How do I buy shares of Liberty Health Sciences?

Shares of LHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Liberty Health Sciences' stock price today?

One share of LHS stock can currently be purchased for approximately $0.53.

What is Liberty Health Sciences' official website?

The official website for Liberty Health Sciences is libertyhealthsciences.com.

How can I contact Liberty Health Sciences?

Liberty Health Sciences' mailing address is 35 McCaul St 2nd Floor, TORONTO, ON M5T 1V7, Canada. The company can be reached via phone at +1-647-7254185.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.